Sex Behavior#MedTooFrNCT05121623
Inappropriate Sexual Behaviour of Patients Towards French General Practitioners
An observational study of Sex Behavior, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.
Trial summary
Occupational sexual harassment (HS) has come to the fore in recent years, particularly with the #MeToo social movement that has encouraged women victims of sexual violence to speak out around the world. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Sex Behavior
- What is being tested?
- Questionnaire
- How many people
- 570 participants
- Where
- 1 siteReunion
- Study dates
- 15 Jan 2022to 22 Mar 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: General practitioners in private practice in France.
Who may be able to join
- Any general practitioner
- Male or female
- Sole or mixed private practice
- Installed or substitute
- Having completed their internship in general medicine
- With or without a thesis
- Practising alone, in a group practice or in a health centre -
Who cannot join
- Specialty other than general medicine
- Exclusive hospital or salaried activity
- Refusal to participate
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Inappropriate Sexual Behaviour (ISB) of Patients Towards French General Practitioners: Prevalence, Nature and Impact on Professional Practice
Occupational sexual harassment (HS) has come to the fore in recent years, particularly with the #MeToo social movement that has encouraged women victims of sexual violence to speak out around the world. The medical profession is not exempt from this phenomenon, whether during the training or professional life of practitioners. In France, very little data is available on this subject, particularly among general practitioners. However, the specific nature of the doctor-patient relationship in general practice makes it a potentially high-risk setting. Furthermore, practitioners' experiences of inappropriate sexual behaviour (ISB) can lead to changes in professional practice, and can thus directly influence the quality of care provided to patients. It is also described in the literature that sexual harassment in physicians is independently associated with a decrease in job satisfaction and sense of security at work, and may be associated with an altered mental health status. To date, the only French studies on ISB and HS in medicine have focused on the period of medical study, and none have looked at the particular problem of the patient as perpetrator of the violence. It is in this context that it has been decided to set up this cross-sectional study with the aim of evaluating the prevalence of ISB occurring during consultations with French general practitioners, to describe their characteristics and to evaluate the responses provided and the repercussions on professional practice.
- Conditions
- Sex Behavior
- Being tested
- Questionnaire
- Medical subject headings
- Sexual Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
Online auto-administered Questionnaire
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence and nature of inappropriate sexual behaviour of patients towards general practitioners in private practice in France
Determined by auto-administered questionnaire (sociodemographic data, personal experience, author's characteristics, reactions and answers provided by the practitioners)
Measured: Once at the inclusion visit
Secondary outcomes (1)
Prevalence and nature of Inappropriate sexual behavior between men and women
To compare the prevalence and nature of Inappropriate sexual behavior according to the gender of the responding physicians determined by auto-administered questionnaire
Measured: Once at the inclusion visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Nov 2021
- Study start15 Jan 2022
- Primary completion15 Jan 2022
- Study completion22 Mar 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sex BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 570 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de la Réunion
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05121623
- Sponsor's protocol ID
- 2021/CHU/18
- Acronym
- #MedTooFr
- Status last verified
- Mar 2022
- First submitted
- 4 Nov 2021
- Last updated
- 1 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Inappropriate Sexual Behaviour (ISB) of Patients Towards French General Practitioners: Prevalence, Nature and Impact on Professional Practice
- ClinicalTrials.gov ID
- NCT05121623
- Acronym / sponsor ID
- #MedTooFr / 2021/CHU/18
- Conditions
- Sex Behavior
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 570 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de la RéunionUniversity, hospital or other
- Study start
- 15 Jan 2022 (actual)
- Primary completion
- 15 Jan 2022 (actual)
- Study completion
- 22 Mar 2022 (actual)
- First posted
- 16 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Occupational sexual harassment (HS) has come to the fore in recent years, particularly with the #MeToo social movement that has encouraged women victims of sexual violence to speak out around the world. The medical profession is not exempt from this phenomenon, whether during the training or professional life of practitioners. In France, very little data is available on this subject, particularly among general practitioners. However, the specific nature of the doctor-patient relationship in general practice makes it a potentially high-risk setting. Furthermore, practitioners' experiences of inappropriate sexual behaviour (ISB) can lead to changes in professional practice, and can thus directly influence the quality of care provided to patients. It is also described in the literature that sexual harassment in physicians is independently associated with a decrease in job satisfaction and sense of security at work, and may be associated with an altered mental health status. To date, the only French studies on ISB and HS in medicine have focused on the period of medical study, and none have looked at the particular problem of the patient as perpetrator of the violence. It is in this context that it has been decided to set up this cross-sectional study with the aim of evaluating the prevalence of ISB occurring during consultations with French general practitioners, to describe their characteristics and to evaluate the responses provided and the repercussions on professional practice.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- General practitioners in private practice in France.
Key inclusion criteria (7 listed)
- Any general practitioner
- Male or female
- Sole or mixed private practice
- Installed or substitute
- Having completed their internship in general medicine
Key exclusion criteria (3 listed)
- Specialty other than general medicine
- Exclusive hospital or salaried activity
- Refusal to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireOnline auto-administered Questionnaire | Other | – |
Primary outcome
Prevalence and nature of inappropriate sexual behaviour of patients towards general practitioners in private practice in France
Time frame: Once at the inclusion visit
Determined by auto-administered questionnaire (sociodemographic data, personal experience, author's characteristics, reactions and answers provided by the practitioners)
1 secondary outcome
Prevalence and nature of Inappropriate sexual behavior between men and women
Time frame: Once at the inclusion visit
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2022.
- Individual participant dataSharing planned: No
Related trials for Sex Behavior
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Recruiting
Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact Lab
Reproductive Health, Sexual Health
Not yet recruiting
HC-HMP: Healthy Choices Implementation Trial
Alcohol Drinking, HIV Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Sex Behavior, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Reunion. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence and nature of inappropriate sexual behaviour of patients towards general practitioners in private practice in France (time frame: Once at the inclusion visit). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2022.